Placebo
ALN-CC5-005
Phase 2 small_molecule terminated
Quick answer
Placebo for IgA Nephropathy (IgAN) is a Phase 2 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- IgA Nephropathy (IgAN)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated